

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 5.75914192 |
| 2 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.60184376 |
| 3 | regulation of skeletal muscle contraction (GO:0014819) | 5.26895740 |
| 4 | actin-myosin filament sliding (GO:0033275) | 4.99696592 |
| 5 | muscle filament sliding (GO:0030049) | 4.99696592 |
| 6 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.78940801 |
| 7 | myofibril assembly (GO:0030239) | 4.70214931 |
| 8 | regulation of relaxation of muscle (GO:1901077) | 4.57187833 |
| 9 | positive regulation of glycolytic process (GO:0045821) | 4.54126206 |
| 10 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.38085821 |
| 11 | actin-mediated cell contraction (GO:0070252) | 4.25954452 |
| 12 | sarcomere organization (GO:0045214) | 4.25842009 |
| 13 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.21503533 |
| 14 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 4.14351010 |
| 15 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.11876259 |
| 16 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.11149911 |
| 17 | regulation of cell communication by electrical coupling (GO:0010649) | 4.06165080 |
| 18 | cardiac myofibril assembly (GO:0055003) | 4.06095737 |
| 19 | fatty acid transmembrane transport (GO:1902001) | 3.82893946 |
| 20 | skeletal muscle adaptation (GO:0043501) | 3.82157443 |
| 21 | interkinetic nuclear migration (GO:0022027) | 3.76563284 |
| 22 | carnitine shuttle (GO:0006853) | 3.66814140 |
| 23 | response to inactivity (GO:0014854) | 3.66107800 |
| 24 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.65136787 |
| 25 | motile cilium assembly (GO:0044458) | 3.60426105 |
| 26 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.54534991 |
| 27 | muscle hypertrophy (GO:0014896) | 3.54207852 |
| 28 | actomyosin structure organization (GO:0031032) | 3.47910901 |
| 29 | negative regulation of gluconeogenesis (GO:0045721) | 3.40508978 |
| 30 | myotube cell development (GO:0014904) | 3.38645034 |
| 31 | regulation of sequestering of triglyceride (GO:0010889) | 3.37105200 |
| 32 | striated muscle contraction (GO:0006941) | 3.33125352 |
| 33 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.31361520 |
| 34 | cardiac muscle hypertrophy (GO:0003300) | 3.28524315 |
| 35 | striated muscle hypertrophy (GO:0014897) | 3.27342280 |
| 36 | regulation of energy homeostasis (GO:2000505) | 3.27178282 |
| 37 | skeletal muscle contraction (GO:0003009) | 3.27112464 |
| 38 | actin filament-based movement (GO:0030048) | 3.26132625 |
| 39 | response to epinephrine (GO:0071871) | 3.24342191 |
| 40 | cardiac muscle contraction (GO:0060048) | 3.18439229 |
| 41 | fatty acid homeostasis (GO:0055089) | 3.15598939 |
| 42 | regulation of actin filament-based movement (GO:1903115) | 3.09276704 |
| 43 | carnitine transmembrane transport (GO:1902603) | 3.02800825 |
| 44 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.94268623 |
| 45 | creatine metabolic process (GO:0006600) | 2.92678347 |
| 46 | muscle contraction (GO:0006936) | 2.91310639 |
| 47 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.91180081 |
| 48 | establishment of protein localization to Golgi (GO:0072600) | 2.89465907 |
| 49 | striated muscle atrophy (GO:0014891) | 2.86711819 |
| 50 | cellular response to epinephrine stimulus (GO:0071872) | 2.86522382 |
| 51 | striated muscle adaptation (GO:0014888) | 2.84174306 |
| 52 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.84135425 |
| 53 | ethanol oxidation (GO:0006069) | 2.82832272 |
| 54 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.82346415 |
| 55 | carnitine transport (GO:0015879) | 2.81192206 |
| 56 | amino-acid betaine transport (GO:0015838) | 2.81192206 |
| 57 | regulation of glycolytic process (GO:0006110) | 2.78378326 |
| 58 | muscle system process (GO:0003012) | 2.77774935 |
| 59 | regulation of striated muscle contraction (GO:0006942) | 2.75913182 |
| 60 | cellular ketone body metabolic process (GO:0046950) | 2.73744461 |
| 61 | protein targeting to Golgi (GO:0000042) | 2.69490228 |
| 62 | skeletal muscle tissue development (GO:0007519) | 2.68868233 |
| 63 | regulation of sarcomere organization (GO:0060297) | 2.68865944 |
| 64 | detection of calcium ion (GO:0005513) | 2.64750565 |
| 65 | regulation of muscle adaptation (GO:0043502) | 2.63040299 |
| 66 | muscle fiber development (GO:0048747) | 2.62143990 |
| 67 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.61617246 |
| 68 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.61617246 |
| 69 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.60578470 |
| 70 | nucleus localization (GO:0051647) | 2.60518405 |
| 71 | positive regulation of cation channel activity (GO:2001259) | 2.59606252 |
| 72 | axoneme assembly (GO:0035082) | 2.59048757 |
| 73 | macroautophagy (GO:0016236) | 2.57159950 |
| 74 | regulation of cardiac muscle hypertrophy (GO:0010611) | 2.56581629 |
| 75 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.56321259 |
| 76 | positive regulation of muscle hypertrophy (GO:0014742) | 2.52463026 |
| 77 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.52463026 |
| 78 | skeletal muscle fiber development (GO:0048741) | 2.50802656 |
| 79 | regulation of muscle hypertrophy (GO:0014743) | 2.50656813 |
| 80 | glycogen catabolic process (GO:0005980) | 2.50535444 |
| 81 | relaxation of muscle (GO:0090075) | 2.48960159 |
| 82 | quaternary ammonium group transport (GO:0015697) | 2.48489486 |
| 83 | regulation of membrane repolarization (GO:0060306) | 2.48129100 |
| 84 | growth hormone receptor signaling pathway (GO:0060396) | 2.47609295 |
| 85 | response to caffeine (GO:0031000) | 2.47565085 |
| 86 | relaxation of cardiac muscle (GO:0055119) | 2.45630877 |
| 87 | ketone body metabolic process (GO:1902224) | 2.44197264 |
| 88 | cGMP-mediated signaling (GO:0019934) | 2.43072889 |
| 89 | negative regulation of complement activation (GO:0045916) | 2.42562219 |
| 90 | muscle atrophy (GO:0014889) | 2.40586087 |
| 91 | muscle tissue morphogenesis (GO:0060415) | 2.36085948 |
| 92 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.35995611 |
| 93 | glucan catabolic process (GO:0009251) | 2.35943203 |
| 94 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.35555449 |
| 95 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.35555449 |
| 96 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.35355753 |
| 97 | transcytosis (GO:0045056) | 2.33710365 |
| 98 | positive regulation of phosphatase activity (GO:0010922) | 2.32532395 |
| 99 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.32495855 |
| 100 | skeletal muscle tissue regeneration (GO:0043403) | 2.31686287 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.58845101 |
| 2 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.49459810 |
| 3 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.42460470 |
| 4 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.11959853 |
| 5 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.07896748 |
| 6 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.06991002 |
| 7 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.04727565 |
| 8 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.96959171 |
| 9 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.94504884 |
| 10 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.85833358 |
| 11 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.85733945 |
| 12 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.85175076 |
| 13 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.82234255 |
| 14 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.81482810 |
| 15 | VDR_22108803_ChIP-Seq_LS180_Human | 1.81039448 |
| 16 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.79593127 |
| 17 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.71692326 |
| 18 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.68365855 |
| 19 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.66223791 |
| 20 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.65538036 |
| 21 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.65516427 |
| 22 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.64221532 |
| 23 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.57800898 |
| 24 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.56108907 |
| 25 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.55044840 |
| 26 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.54526871 |
| 27 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.52689029 |
| 28 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.51704612 |
| 29 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.51610208 |
| 30 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.50285942 |
| 31 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.49242152 |
| 32 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.47821094 |
| 33 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.47251272 |
| 34 | CJUN_26792858_Chip-Seq_BT549_Human | 1.46611417 |
| 35 | STAT3_23295773_ChIP-Seq_U87_Human | 1.46371871 |
| 36 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.41095572 |
| 37 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.35893675 |
| 38 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.35824924 |
| 39 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.35488700 |
| 40 | TCF4_23295773_ChIP-Seq_U87_Human | 1.35054654 |
| 41 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.34750922 |
| 42 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.34750922 |
| 43 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.33929274 |
| 44 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.31692011 |
| 45 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.31137608 |
| 46 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.29982536 |
| 47 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.29058029 |
| 48 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28222884 |
| 49 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.27763487 |
| 50 | AR_25329375_ChIP-Seq_VCAP_Human | 1.27664775 |
| 51 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.26992352 |
| 52 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.25695080 |
| 53 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.25197694 |
| 54 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.24576073 |
| 55 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.24576073 |
| 56 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.21193749 |
| 57 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.21193749 |
| 58 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20371596 |
| 59 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.20002411 |
| 60 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.18493122 |
| 61 | P300_19829295_ChIP-Seq_ESCs_Human | 1.16675779 |
| 62 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.15948749 |
| 63 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.14918640 |
| 64 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.14657093 |
| 65 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.14310936 |
| 66 | TP53_16413492_ChIP-PET_HCT116_Human | 1.13033836 |
| 67 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.11272818 |
| 68 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.07721279 |
| 69 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.07653643 |
| 70 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.07562582 |
| 71 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.07524286 |
| 72 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.07423836 |
| 73 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.07334993 |
| 74 | FUS_26573619_Chip-Seq_HEK293_Human | 1.06774244 |
| 75 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.05710598 |
| 76 | TBL1_22424771_ChIP-Seq_293T_Human | 1.05369443 |
| 77 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.02751397 |
| 78 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.02682047 |
| 79 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.02446086 |
| 80 | KDM2B_26808549_Chip-Seq_REH_Human | 1.02187888 |
| 81 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.01998443 |
| 82 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.01928657 |
| 83 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.01738270 |
| 84 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.00945056 |
| 85 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.99943916 |
| 86 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.98915246 |
| 87 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.98514824 |
| 88 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.98255094 |
| 89 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.97919767 |
| 90 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97533268 |
| 91 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.97376569 |
| 92 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.95722247 |
| 93 | GATA1_22025678_ChIP-Seq_K562_Human | 0.95558926 |
| 94 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.95356587 |
| 95 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.94852569 |
| 96 | RXR_22108803_ChIP-Seq_LS180_Human | 0.93399323 |
| 97 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.93029463 |
| 98 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.92571543 |
| 99 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.92316825 |
| 100 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.92316825 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000751_myopathy | 4.77133450 |
| 2 | MP0003646_muscle_fatigue | 4.39002845 |
| 3 | MP0005275_abnormal_skin_tensile | 3.60001675 |
| 4 | MP0000749_muscle_degeneration | 3.55331046 |
| 5 | MP0004145_abnormal_muscle_electrophysio | 3.33669510 |
| 6 | MP0005670_abnormal_white_adipose | 3.30110338 |
| 7 | MP0004036_abnormal_muscle_relaxation | 3.15062188 |
| 8 | MP0008438_abnormal_cutaneous_collagen | 3.12519607 |
| 9 | MP0004084_abnormal_cardiac_muscle | 2.95915606 |
| 10 | MP0005503_abnormal_tendon_morphology | 2.95727196 |
| 11 | MP0004130_abnormal_muscle_cell | 2.92074571 |
| 12 | MP0000013_abnormal_adipose_tissue | 2.90700465 |
| 13 | MP0001661_extended_life_span | 2.74206260 |
| 14 | MP0004215_abnormal_myocardial_fiber | 2.60481927 |
| 15 | MP0002837_dystrophic_cardiac_calcinosis | 2.58561119 |
| 16 | MP0002108_abnormal_muscle_morphology | 2.57457445 |
| 17 | MP0004087_abnormal_muscle_fiber | 2.27013979 |
| 18 | MP0005620_abnormal_muscle_contractility | 2.21175230 |
| 19 | MP0009780_abnormal_chondrocyte_physiolo | 2.16467441 |
| 20 | MP0002106_abnormal_muscle_physiology | 2.10192601 |
| 21 | MP0000747_muscle_weakness | 2.08688798 |
| 22 | MP0005369_muscle_phenotype | 2.07754840 |
| 23 | MP0003950_abnormal_plasma_membrane | 1.99503245 |
| 24 | MP0006138_congestive_heart_failure | 1.99473779 |
| 25 | MP0002269_muscular_atrophy | 1.94472527 |
| 26 | MP0000759_abnormal_skeletal_muscle | 1.93399485 |
| 27 | MP0005330_cardiomyopathy | 1.93336349 |
| 28 | MP0010368_abnormal_lymphatic_system | 1.86358892 |
| 29 | MP0002971_abnormal_brown_adipose | 1.81015602 |
| 30 | MP0002332_abnormal_exercise_endurance | 1.74233661 |
| 31 | MP0000750_abnormal_muscle_regeneration | 1.67350805 |
| 32 | MP0002972_abnormal_cardiac_muscle | 1.66949388 |
| 33 | MP0005666_abnormal_adipose_tissue | 1.64034896 |
| 34 | MP0005375_adipose_tissue_phenotype | 1.56499487 |
| 35 | MP0003045_fibrosis | 1.55360680 |
| 36 | MP0004510_myositis | 1.54913874 |
| 37 | MP0002876_abnormal_thyroid_physiology | 1.51504513 |
| 38 | MP0000003_abnormal_adipose_tissue | 1.47762472 |
| 39 | MP0004484_altered_response_of | 1.46288874 |
| 40 | MP0005266_abnormal_metabolism | 1.31969036 |
| 41 | MP0002638_abnormal_pupillary_reflex | 1.29866889 |
| 42 | MP0005385_cardiovascular_system_phenoty | 1.24603271 |
| 43 | MP0001544_abnormal_cardiovascular_syste | 1.24603271 |
| 44 | MP0003879_abnormal_hair_cell | 1.23876882 |
| 45 | MP0003137_abnormal_impulse_conducting | 1.22999984 |
| 46 | MP0010329_abnormal_lipoprotein_level | 1.22229248 |
| 47 | MP0001501_abnormal_sleep_pattern | 1.21242672 |
| 48 | MP0005535_abnormal_body_temperature | 1.18769447 |
| 49 | MP0009115_abnormal_fat_cell | 1.17818552 |
| 50 | MP0004085_abnormal_heartbeat | 1.11226305 |
| 51 | MP0000733_abnormal_muscle_development | 1.06600155 |
| 52 | MP0002127_abnormal_cardiovascular_syste | 1.05582824 |
| 53 | MP0002078_abnormal_glucose_homeostasis | 1.01951702 |
| 54 | MP0009384_cardiac_valve_regurgitation | 1.00739503 |
| 55 | MP0000230_abnormal_systemic_arterial | 1.00118930 |
| 56 | MP0006036_abnormal_mitochondrial_physio | 0.99862014 |
| 57 | MP0002118_abnormal_lipid_homeostasis | 0.99450018 |
| 58 | MP0008775_abnormal_heart_ventricle | 0.98916061 |
| 59 | MP0005171_absent_coat_pigmentation | 0.98143514 |
| 60 | MP0001879_abnormal_lymphatic_vessel | 0.97925148 |
| 61 | MP0003868_abnormal_feces_composition | 0.96984142 |
| 62 | MP0003195_calcinosis | 0.96078075 |
| 63 | MP0010630_abnormal_cardiac_muscle | 0.96066414 |
| 64 | MP0001958_emphysema | 0.93256268 |
| 65 | MP0002295_abnormal_pulmonary_circulatio | 0.90930701 |
| 66 | MP0005167_abnormal_blood-brain_barrier | 0.89472147 |
| 67 | MP0004043_abnormal_pH_regulation | 0.89463033 |
| 68 | MP0000372_irregular_coat_pigmentation | 0.88308856 |
| 69 | MP0002138_abnormal_hepatobiliary_system | 0.87898338 |
| 70 | MP0002909_abnormal_adrenal_gland | 0.87516864 |
| 71 | MP0001984_abnormal_olfaction | 0.86520395 |
| 72 | MP0002933_joint_inflammation | 0.85493622 |
| 73 | MP0003828_pulmonary_edema | 0.85033006 |
| 74 | MP0008057_abnormal_DNA_replication | 0.84991671 |
| 75 | MP0005334_abnormal_fat_pad | 0.84198467 |
| 76 | MP0001299_abnormal_eye_distance/ | 0.83938441 |
| 77 | MP0003279_aneurysm | 0.83175767 |
| 78 | MP0002168_other_aberrant_phenotype | 0.80963246 |
| 79 | MP0009046_muscle_twitch | 0.77147367 |
| 80 | MP0005448_abnormal_energy_balance | 0.76745126 |
| 81 | MP0005595_abnormal_vascular_smooth | 0.76175874 |
| 82 | MP0004272_abnormal_basement_membrane | 0.75808208 |
| 83 | MP0005332_abnormal_amino_acid | 0.71227949 |
| 84 | MP0005451_abnormal_body_composition | 0.70662389 |
| 85 | MP0004270_analgesia | 0.69370734 |
| 86 | MP0003252_abnormal_bile_duct | 0.68217577 |
| 87 | MP0010386_abnormal_urinary_bladder | 0.66753874 |
| 88 | MP0005645_abnormal_hypothalamus_physiol | 0.66637214 |
| 89 | MP0004233_abnormal_muscle_weight | 0.66067539 |
| 90 | MP0009643_abnormal_urine_homeostasis | 0.65152109 |
| 91 | MP0005085_abnormal_gallbladder_physiolo | 0.65014530 |
| 92 | MP0002693_abnormal_pancreas_physiology | 0.63087355 |
| 93 | MP0003959_abnormal_lean_body | 0.63036890 |
| 94 | MP0002128_abnormal_blood_circulation | 0.62004663 |
| 95 | MP0002970_abnormal_white_adipose | 0.61800392 |
| 96 | MP0005452_abnormal_adipose_tissue | 0.59127034 |
| 97 | MP0003690_abnormal_glial_cell | 0.57978617 |
| 98 | MP0005376_homeostasis/metabolism_phenot | 0.56694079 |
| 99 | MP0003953_abnormal_hormone_level | 0.55152841 |
| 100 | MP0005253_abnormal_eye_physiology | 0.54109429 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nemaline bodies (HP:0003798) | 7.09179175 |
| 2 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 6.70112213 |
| 3 | Muscle fiber inclusion bodies (HP:0100299) | 6.68726574 |
| 4 | Type 1 muscle fiber predominance (HP:0003803) | 5.84424105 |
| 5 | Exercise-induced myalgia (HP:0003738) | 5.40374980 |
| 6 | Muscle fiber splitting (HP:0003555) | 4.52581363 |
| 7 | Abnormality of the calf musculature (HP:0001430) | 4.18570950 |
| 8 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.14241936 |
| 9 | Calf muscle hypertrophy (HP:0008981) | 4.12080531 |
| 10 | Hyporeflexia of lower limbs (HP:0002600) | 4.05222280 |
| 11 | Bundle branch block (HP:0011710) | 3.96320395 |
| 12 | EMG: myopathic abnormalities (HP:0003458) | 3.79795589 |
| 13 | Sudden death (HP:0001699) | 3.79481150 |
| 14 | Neck muscle weakness (HP:0000467) | 3.60233502 |
| 15 | Distal arthrogryposis (HP:0005684) | 3.58363315 |
| 16 | Myoglobinuria (HP:0002913) | 3.49188724 |
| 17 | Increased connective tissue (HP:0009025) | 3.42085116 |
| 18 | Hyperkalemia (HP:0002153) | 3.36437652 |
| 19 | Difficulty running (HP:0009046) | 3.35534788 |
| 20 | Exercise-induced muscle cramps (HP:0003710) | 3.32380234 |
| 21 | Round ear (HP:0100830) | 3.31355841 |
| 22 | Absent/shortened dynein arms (HP:0200106) | 3.28461432 |
| 23 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.28461432 |
| 24 | Myopathic facies (HP:0002058) | 3.25001855 |
| 25 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.09562023 |
| 26 | Aortic aneurysm (HP:0004942) | 3.04574254 |
| 27 | Frequent falls (HP:0002359) | 3.00534995 |
| 28 | Increased variability in muscle fiber diameter (HP:0003557) | 2.94582421 |
| 29 | Asymmetric septal hypertrophy (HP:0001670) | 2.77758701 |
| 30 | Decreased circulating renin level (HP:0003351) | 2.76065910 |
| 31 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.73740398 |
| 32 | Hypoglycemic coma (HP:0001325) | 2.73366279 |
| 33 | Rimmed vacuoles (HP:0003805) | 2.70838734 |
| 34 | Rhabdomyolysis (HP:0003201) | 2.68191282 |
| 35 | Lipoatrophy (HP:0100578) | 2.66988467 |
| 36 | Atrial fibrillation (HP:0005110) | 2.66239606 |
| 37 | Ventricular tachycardia (HP:0004756) | 2.65495172 |
| 38 | Heart block (HP:0012722) | 2.62103269 |
| 39 | Muscular dystrophy (HP:0003560) | 2.54372821 |
| 40 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.51285618 |
| 41 | Hyperglycemia (HP:0003074) | 2.48681975 |
| 42 | Dilated cardiomyopathy (HP:0001644) | 2.48324746 |
| 43 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.47934523 |
| 44 | Subaortic stenosis (HP:0001682) | 2.47934523 |
| 45 | Abnormal atrioventricular conduction (HP:0005150) | 2.45501317 |
| 46 | Ketoacidosis (HP:0001993) | 2.44633123 |
| 47 | Syncope (HP:0001279) | 2.43215255 |
| 48 | Hypoglycemic seizures (HP:0002173) | 2.42037428 |
| 49 | Primary atrial arrhythmia (HP:0001692) | 2.42009435 |
| 50 | Distal lower limb muscle weakness (HP:0009053) | 2.37999756 |
| 51 | Hypoalphalipoproteinemia (HP:0003233) | 2.36822424 |
| 52 | Dysmetric saccades (HP:0000641) | 2.35948790 |
| 53 | Ulnar deviation of the wrist (HP:0003049) | 2.34817670 |
| 54 | Gowers sign (HP:0003391) | 2.33725536 |
| 55 | EMG: neuropathic changes (HP:0003445) | 2.32867667 |
| 56 | Wrist flexion contracture (HP:0001239) | 2.29160448 |
| 57 | Oligomenorrhea (HP:0000876) | 2.25770881 |
| 58 | Complement deficiency (HP:0004431) | 2.25099396 |
| 59 | Supraventricular tachycardia (HP:0004755) | 2.24252684 |
| 60 | Striae distensae (HP:0001065) | 2.24231598 |
| 61 | Myotonia (HP:0002486) | 2.24124717 |
| 62 | Large for gestational age (HP:0001520) | 2.23441743 |
| 63 | Generalized muscle weakness (HP:0003324) | 2.20290821 |
| 64 | Abnormality of the ischium (HP:0003174) | 2.19117611 |
| 65 | Malignant hyperthermia (HP:0002047) | 2.18456906 |
| 66 | Supraventricular arrhythmia (HP:0005115) | 2.17465437 |
| 67 | Hypoplastic ischia (HP:0003175) | 2.16481218 |
| 68 | Fetal akinesia sequence (HP:0001989) | 2.15507512 |
| 69 | Hyperlipoproteinemia (HP:0010980) | 2.14122575 |
| 70 | Areflexia of lower limbs (HP:0002522) | 2.13382088 |
| 71 | Prolonged QT interval (HP:0001657) | 2.11445914 |
| 72 | Ventricular arrhythmia (HP:0004308) | 2.11195561 |
| 73 | Proximal amyotrophy (HP:0007126) | 2.07148734 |
| 74 | Bell-shaped thorax (HP:0001591) | 2.06939205 |
| 75 | Fair hair (HP:0002286) | 2.04654377 |
| 76 | Bulbar palsy (HP:0001283) | 2.03675369 |
| 77 | Abnormality of potassium homeostasis (HP:0011042) | 2.02188846 |
| 78 | Abnormal ciliary motility (HP:0012262) | 2.01287347 |
| 79 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.97740939 |
| 80 | Absent phalangeal crease (HP:0006109) | 1.97060501 |
| 81 | Blue irides (HP:0000635) | 1.96667332 |
| 82 | Atrioventricular block (HP:0001678) | 1.95984853 |
| 83 | Right ventricular cardiomyopathy (HP:0011663) | 1.89519236 |
| 84 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.86126950 |
| 85 | Facial diplegia (HP:0001349) | 1.85307248 |
| 86 | Abnormality of the neuromuscular junction (HP:0003398) | 1.84641448 |
| 87 | Fatigable weakness (HP:0003473) | 1.84641448 |
| 88 | Pigmentary retinal degeneration (HP:0001146) | 1.84148543 |
| 89 | Left ventricular hypertrophy (HP:0001712) | 1.83459074 |
| 90 | Ketosis (HP:0001946) | 1.82229673 |
| 91 | Abnormal finger flexion creases (HP:0006143) | 1.82124128 |
| 92 | Hip contracture (HP:0003273) | 1.80248900 |
| 93 | Neoplasm of the heart (HP:0100544) | 1.77434455 |
| 94 | Abnormal EKG (HP:0003115) | 1.76512587 |
| 95 | Insulin resistance (HP:0000855) | 1.76007097 |
| 96 | Ventricular fibrillation (HP:0001663) | 1.73666143 |
| 97 | Hypokalemia (HP:0002900) | 1.72459957 |
| 98 | Mitral stenosis (HP:0001718) | 1.70692714 |
| 99 | Abnormality of the renal cortex (HP:0011035) | 1.69364312 |
| 100 | Abnormality of complement system (HP:0005339) | 1.68652266 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 6.97281751 |
| 2 | FRK | 5.06471784 |
| 3 | PHKG2 | 3.56406456 |
| 4 | PHKG1 | 3.56406456 |
| 5 | TTN | 2.55101055 |
| 6 | EPHA3 | 2.53039257 |
| 7 | MYLK | 2.39102151 |
| 8 | MAP3K7 | 2.34125513 |
| 9 | PINK1 | 2.15178102 |
| 10 | TRPM7 | 2.01718460 |
| 11 | PIK3CG | 1.91756743 |
| 12 | PRKAA2 | 1.87855578 |
| 13 | MUSK | 1.77050402 |
| 14 | ACVR1B | 1.76808021 |
| 15 | MAPK7 | 1.54908360 |
| 16 | NLK | 1.52815378 |
| 17 | MAPK12 | 1.45206925 |
| 18 | AKT3 | 1.38516495 |
| 19 | TIE1 | 1.36038783 |
| 20 | FER | 1.25955312 |
| 21 | BLK | 1.19350492 |
| 22 | TGFBR2 | 1.15116924 |
| 23 | DDR2 | 1.07552080 |
| 24 | PTK2B | 1.07364833 |
| 25 | SGK2 | 1.07326285 |
| 26 | DMPK | 1.05507221 |
| 27 | NEK9 | 1.05435590 |
| 28 | PIK3CA | 1.04760380 |
| 29 | PRKAA1 | 1.04323679 |
| 30 | BMPR1B | 1.03213029 |
| 31 | PAK3 | 1.02218539 |
| 32 | DAPK2 | 1.02178610 |
| 33 | MAP3K4 | 1.01471888 |
| 34 | FGFR3 | 0.98906748 |
| 35 | EPHB1 | 0.97323152 |
| 36 | CAMK1 | 0.94381892 |
| 37 | NTRK3 | 0.90764096 |
| 38 | CAMK2D | 0.90464407 |
| 39 | CDC42BPA | 0.89660999 |
| 40 | MAPKAPK3 | 0.88028075 |
| 41 | LATS1 | 0.84344052 |
| 42 | LMTK2 | 0.83464441 |
| 43 | PRKG1 | 0.82875753 |
| 44 | MAP4K2 | 0.81307533 |
| 45 | ERBB3 | 0.80122447 |
| 46 | STK38L | 0.77487639 |
| 47 | MARK2 | 0.76679373 |
| 48 | INSRR | 0.73936333 |
| 49 | CAMK2G | 0.71228168 |
| 50 | STK38 | 0.71022197 |
| 51 | PDK2 | 0.70002857 |
| 52 | IRAK1 | 0.67246986 |
| 53 | PRKD1 | 0.66340435 |
| 54 | CAMK4 | 0.62537307 |
| 55 | MARK1 | 0.61734468 |
| 56 | CAMK2A | 0.61170071 |
| 57 | CAMK2B | 0.61085516 |
| 58 | PKN1 | 0.60682315 |
| 59 | MAPK4 | 0.59614557 |
| 60 | STK24 | 0.59231736 |
| 61 | JAK1 | 0.58444840 |
| 62 | MAP3K6 | 0.58311397 |
| 63 | SGK3 | 0.58041803 |
| 64 | STK11 | 0.57890423 |
| 65 | PRKCE | 0.57784265 |
| 66 | MAP2K6 | 0.57306649 |
| 67 | MAP2K1 | 0.56128441 |
| 68 | TGFBR1 | 0.55926997 |
| 69 | WNK1 | 0.55228126 |
| 70 | MAPK11 | 0.55153936 |
| 71 | PRKACA | 0.54059233 |
| 72 | SGK494 | 0.52525619 |
| 73 | SGK223 | 0.52525619 |
| 74 | STK3 | 0.52372309 |
| 75 | OXSR1 | 0.52293109 |
| 76 | LIMK1 | 0.51935176 |
| 77 | HIPK2 | 0.51464261 |
| 78 | MAPK15 | 0.50805692 |
| 79 | GRK5 | 0.49820777 |
| 80 | GRK1 | 0.48746714 |
| 81 | MAP3K2 | 0.47309778 |
| 82 | PDGFRB | 0.47029258 |
| 83 | ROCK1 | 0.46179836 |
| 84 | FGFR2 | 0.45916809 |
| 85 | PRKACG | 0.44988540 |
| 86 | EEF2K | 0.44047888 |
| 87 | RPS6KA3 | 0.43118382 |
| 88 | ADRBK1 | 0.42580505 |
| 89 | MAP2K4 | 0.40719055 |
| 90 | PRKACB | 0.40479868 |
| 91 | PDPK1 | 0.40075034 |
| 92 | KIT | 0.39474991 |
| 93 | PRKG2 | 0.39377483 |
| 94 | MET | 0.36866461 |
| 95 | MST1R | 0.35702466 |
| 96 | SGK1 | 0.34222297 |
| 97 | EPHA4 | 0.33414733 |
| 98 | PDGFRA | 0.32631766 |
| 99 | ITK | 0.30665285 |
| 100 | PDK1 | 0.30040694 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.62403027 |
| 2 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.53928801 |
| 3 | Circadian rhythm_Homo sapiens_hsa04710 | 2.34974741 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.21652337 |
| 5 | * ABC transporters_Homo sapiens_hsa02010 | 2.04485076 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.00282376 |
| 7 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.98023490 |
| 8 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.94777949 |
| 9 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.94252513 |
| 10 | Histidine metabolism_Homo sapiens_hsa00340 | 1.82609466 |
| 11 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.71942666 |
| 12 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.67476348 |
| 13 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.66362106 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 1.64995860 |
| 15 | Renin secretion_Homo sapiens_hsa04924 | 1.62758039 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.62294580 |
| 17 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.48913084 |
| 18 | Insulin resistance_Homo sapiens_hsa04931 | 1.43238661 |
| 19 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.40148063 |
| 20 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.39673633 |
| 21 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.34839335 |
| 22 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.34759142 |
| 23 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.32829556 |
| 24 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.31811831 |
| 25 | Retinol metabolism_Homo sapiens_hsa00830 | 1.30565403 |
| 26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.30280880 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.27605166 |
| 28 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.27282612 |
| 29 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.25288408 |
| 30 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.24332730 |
| 31 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.20964643 |
| 32 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.19351315 |
| 33 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.18854223 |
| 34 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.18186766 |
| 35 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.17827073 |
| 36 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.17276032 |
| 37 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.16993749 |
| 38 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.14375005 |
| 39 | Circadian entrainment_Homo sapiens_hsa04713 | 1.12920654 |
| 40 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.12237522 |
| 41 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.11495653 |
| 42 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.11166079 |
| 43 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.10693207 |
| 44 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.10689836 |
| 45 | Bile secretion_Homo sapiens_hsa04976 | 1.10597208 |
| 46 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.08201587 |
| 47 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.06534215 |
| 48 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.06298665 |
| 49 | Salivary secretion_Homo sapiens_hsa04970 | 1.05819155 |
| 50 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.04534968 |
| 51 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.02598132 |
| 52 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.01360522 |
| 53 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.96382074 |
| 54 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.95950579 |
| 55 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.94841513 |
| 56 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.90622356 |
| 57 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.88593666 |
| 58 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.86627182 |
| 59 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.83731915 |
| 60 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.80977689 |
| 61 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.80955331 |
| 62 | Focal adhesion_Homo sapiens_hsa04510 | 0.80929317 |
| 63 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.80437955 |
| 64 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.80335185 |
| 65 | Long-term depression_Homo sapiens_hsa04730 | 0.77740000 |
| 66 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.77383497 |
| 67 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.71648252 |
| 68 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.70142513 |
| 69 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.69967127 |
| 70 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.69032157 |
| 71 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.68513053 |
| 72 | Lysine degradation_Homo sapiens_hsa00310 | 0.68074343 |
| 73 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.65335687 |
| 74 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.65118016 |
| 75 | Morphine addiction_Homo sapiens_hsa05032 | 0.64193988 |
| 76 | Mineral absorption_Homo sapiens_hsa04978 | 0.62011777 |
| 77 | Platelet activation_Homo sapiens_hsa04611 | 0.61954075 |
| 78 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.61770660 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.60543438 |
| 80 | GABAergic synapse_Homo sapiens_hsa04727 | 0.60146878 |
| 81 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.59932561 |
| 82 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.58774838 |
| 83 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.57248979 |
| 84 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.57215846 |
| 85 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.54893585 |
| 86 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.54310072 |
| 87 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.53786069 |
| 88 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.53499208 |
| 89 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.52323168 |
| 90 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.51674808 |
| 91 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.51377969 |
| 92 | Tight junction_Homo sapiens_hsa04530 | 0.51152713 |
| 93 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.50317734 |
| 94 | Taste transduction_Homo sapiens_hsa04742 | 0.49694725 |
| 95 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.49120447 |
| 96 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.48511799 |
| 97 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.48147179 |
| 98 | Peroxisome_Homo sapiens_hsa04146 | 0.47498711 |
| 99 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.47431339 |
| 100 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.36473311 |

